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Abstract: Upper extremities limitation is a common functional impairment in patients with Mul-
tiple Sclerosis (PwMS). Novel technological devices are increasingly used in neurorehabilitation
to support motor function improvement and the quantitative assessment of motor performance
during training in patients with neurological diseases. In this review, we systematically report the
evidence on clinical applications and robotic-assisted arm training (RAT) in functional recovery
in PwMS. PubMed/MEDLINE, the Cochrane Library, and the Physiotherapy Evidence Database
(PEDro) databases were systematically searched from inception to March 2021. The 10-item PEDro
scale assessed the study quality for the RCT, and the AMSTAR-2 was used to assess the quality of the
systematic review. The 5-item Oxford CEBM scale was used to rate the level of evidence. A total of
10 studies (161 subjects) were included. The selected studies included one systematic review, four
RCTs, one randomized crossover, and four case series. The RCTs were scored as high-quality studies,
while the systematic review was determined to be of low quality. Shoulder range of motion, handgrip
strength, and proximal arm impairment improved after RAT. Manual dexterity, arm function, and use
in daily life also ameliorated arm function. The high clinical heterogeneity of treatment programs and
the variety of robot devices affects the generalizability of the study results; therefore, we emphasize
the need to standardize the intervention type in future studies that evaluate the role of robotic-assisted
training in PwMS. Robot-assisted treatment seems safe and useful to increase manual dexterity and
the quality of movement execution in PwMS with moderate to severe disability. Additional studies
with an adequate sample size and methodological rigour are warranted to drive definite conclusions.
Keywords: multiple sclerosis; robotic devices; rehabilitation; exoskeleton
1. Introduction
Multiple sclerosis (MS) is an inflammatory, neurodegenerative, demyelinating disorder
of the Central Nervous System [1] with pathology progression that is highly variable among
patients [2]. About 76% of patients with MS (PwMS) experience upper limb dysfunction [3],
and 30% show functionally relevant cerebellar deficits such as tremor and ataxia [4,5].
Among them, 68% show bilateral disorders in sensation, strength, and dexterity [6,7]. More-
over, robot-derived measures have revealed that PwMS show irregular arm trajectories;
abnormalities in muscle synergies, timing, and organization [8]; and impaired movement
execution, even at the early stages of the disease [9]. The clinical manifestations of MS
include a wide range of neurological symptoms that can compromise essential functions,
including cognitive and sensorimotor skills, resulting in deficits such as muscle weakness
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and lack of movement coordination. These limitations negatively influence the quality of
life [10], home integration, and social participation [11,12] of PwMS.
While MS is degenerative, the impact of MS on disability progression can be limited
by functional reorganization processes that leverage neural plasticity [13]. Indeed, data
show that motor-learning skills [14] and force field adaptation during a robot-assisted
reaching task [9] are still present in PwMS. This makes PwMS good candidates for re-
habilitative strategies that build on plasticity and learning, such as arm robotics. These
techniques provide a motivating, cognitive-engaged environment for high-intensity skilled
movement training [15,16] and are thought to engage neuroplasticity [17] and learning [18]
to mediate their effects. While robot-assisted rehabilitation was originated in the stroke
field [19,20], in PwMS, it has been extensively studied for gait rehabilitation [21]. However,
treatment efforts that are focused on upper-limb rehabilitation are especially necessary
in the advanced stages of the disease, and studies show that multidisciplinary and robot-
assisted rehabilitation approaches are capable of improving the upper limb capacity in
PwMS [22,23].
Considering the peculiar pathophysiology of disorders in Multiple Sclerosis, which
differs from cerebrovascular pathophysiology, it is essential to identify specific fields for
robotic device applications for PwMS. Therefore, this review aims to systematically report
the evidence on the effectiveness of the clinical applications of robotic-assisted upper
limb-therapy in PwMS.
2. Materials and Methods
The Upper Limb Robotics working group carried out the present study within the
framework of the Italian Consensus Conference on “Rehabilitation assisted by robotic and
electromechanical devices for persons with disability of neurological origin” (CICERONE),
promoted by the Italian Society of Physical and Rehabilitation Medicine (SIMFER, So-
cietà Italiana di Medicina Fisica e Riabilitativa) and the Italian Society of Neurological
Rehabilitation (SIRN, Società Italiana di Riabilitazione Neurologica) (2019–2021) [24].
2.1. Search Strategy
PubMed/MEDLINE, the Cochrane Library, and the Physiotherapy Evidence Database
(PEDro) databases were systematically searched from their inception to March 2021 using
the following keywords: “multiple sclerosis” and “robot” and “upper limb”. An example
of the full search strategy for PubMed/MEDLINE is as follows: (Multiple Sclerosis [Ti-
tle/Abstract]) OR Multiple sclerosis [MeSH Terms] AND ((((robot*[Title/Abstract]) OR
exoskeleton[Title/Abstract]) OR end-effector[Title/Abstract]) OR robotics[MeSH Terms])
OR Exoskeleton Device[MeSH Terms] AND ((((((upper limb[Title/Abstract]) OR upper
extremity[Title/Abstract]) OR hand[Title/Abstract]) OR arm[Title/Abstract]) OR upper
extremity[MeSH Terms])). This systematic review was performed in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) state-
ment [25].
2.2. Selection Criteria
After duplicates were removed, two reviewers independently screened for inclusion
based on the title and abstract of all of the potentially relevant studies that had been
identified. In case of disagreement, a consensus was achieved by the decision of a third
reviewer. Full-text studies were subsequently retrieved by the same two reviewers and were
independently screened for inclusion. If consensus was not reached through discussion
between them, disagreements were solved by the decision of a third reviewer. Studies
were considered eligible if they were able to answer the questions that have been defined
according to the following PICO model:
1. (P) Participants: PwMS
2. (I) Intervention: Rehabilitation training with robotic-assisted device for upper limbs,
with or without conventional therapy.
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3. (C) Comparator: Conventional rehabilitation.
4. (O) Outcome measures: Safety of robotic rehabilitation, the feasibility of robotic
rehabilitation, upper limb strength, functioning, independence in activity of daily
living (ADL), and Health-related Quality of Life (HRQoL).
We included systematic reviews, randomized controlled trials (RCTs), observational
analytic studies, and crossover and case series. The exclusion criteria were (1) papers
involving animals; (2) papers that had been written in language other than English; (3)
a case report design; (4) participants with neurologic disabilities other than MS; and (5)
robotic-assisted rehabilitation combined with other advanced technologies such as non-
invasive brain stimulation (NIBS) compared to robot-assisted therapy alone.
2.3. Data Extraction and Synthesis
All of the data were extracted from eligible full-text documents through Excel by two
different authors. In case of disagreement, a consensus was achieved by the review of a
third author. The following data were extracted: (1) title; (2) authors; (3) publication year;
(4) study design; (5) participants; (6) intervention characteristics; (7) outcomes; and (8) main
findings. All of the studies that were included in the review were synthesized, describing
both the study characteristics and the data that were extracted. Given the high clinical
heterogeneity in design, intervention, and outcomes that were assessed in the different
studies, a meta-analysis was not performed.
2.4. Quality Assessment
The study’s risk of bias was assessed by the AMSTAR-2 [26] for systematic reviews
and the 10-item PEDro scale [27] for RCT studies. Two different authors rated the studies
that were included in this review. If consensus was not achieved after discussion, a third
reviewer was interrogated. The 5-item Oxford CEBM scale was used to rate the level of
evidence [28] (OCEBM website).
3. Results
After the databases were searched, 320 records were identified, of which 29 were
assessed for full-text screening eligibility. Finally, ten studies were included in the quali-
tative analysis that verified the effect of robotic therapy in the upper limb rehabilitation
in PwMS [16,29–37]. A summary of the search and study selection process is shown in
Figure 1.
The ten selected studies included one systematic review [16]; four RCTs [29,30,32,33];
one randomized crossover study [35]; and four case series [31,34,36,37]. A summary of the
characteristics and results of the included studies are reported in Table 1.
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Table 1. Main characteristics of the studies included in this review and related CEBM levels of
evidence.
Author, Year Study Design Population Intervention Outcomes CEBM Levelof Evidence
Solaro et al.,
2020 RCT
36 PwMS: 13 PP,
15 SP, 8 RR
EDSS 5–6
R: shoulder, elbow, forearm, wrist,
robot-assisted with haptic exercises
(Braccio di Ferro)
C: shoulder, elbow, forearm, wrist,
robot-assisted with sensorimotor exercises
(Braccio di Ferro)
D: 8 sessions, 2 sessions a week for 4
weeks. Sessions lasted40 min.
(+) 9HPT and robotic
instrumental outcomes






44 PwMS: 3 PP,
15 SP, 26 RR
EDSS 6
R: hand r bot-assisted training (Amadeo®,
Tyromotion, Austria)
C: conventional therapy
D: 10 sessions, 2 sessions a week for 5
weeks. Session lasting 50 min.
(+) MAL, LifeH and







13 PwMS: 2 PP, 6
SP, 3 RR, 2 RP
EDSS 6.5
R: shoulder, elbow, forearm, wrist
robot-assisted training (Haptic Master,
MOOG, Netherlands)
C: NA
D: 40 sessions, 5 times a week for 8 weeks.
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Table 1. Cont.
Author, Year Study Design Population Intervention Outcomes CEBM Levelof Evidence
Sampson et al.,
2016 Case Series
5 PwMS: 1 PP, 3
SP, 1 RR
EDSS NA
R: shoulder, elbow, forearm, wrist training
(Armeo Spring, Hocoma, Switzerland) +
FES
C: NA
D: 18 treatment sessions over a 10 weeks
period. frequency not described
(+) FMA proximal arm
section, the accuracy of
tracking performance
4
Feys et al., 2015 RCT
17 PwMS: 2 PP,
14 SP, 1 RR
EDSS 8
R: shoulder, elbow, forearm, wrist
robot-assisted training + conventional
multidisciplinary therapy (Haptic Master,
MOOG, Netherlands)
C: conventional multidisciplinary therapy
D: 24 sessions, 3 times a week for 8 weeks.
Session lasting 30 min of robotic therapy









et al., 2012 RCT
22 PwMS: 4 PP,
12 SP, 6 RR
EDSS 6.7
R: shoulder, elbow, forearm, wrist,
robot-assisted reaching task (Braccio di
Ferro) and object manipulation (RMT)
C: shoulder, elbow, forearm, wrist,
robot-assisted reaching task, RT (Braccio
di Ferro)
D: 8 sessions, 160 movements each session.
Session lasting 30–45 min.
(+) grasp—ARAT, TSS
RMT was superior to RT





9 PwMS: 3 PP, 6
SP
EDSS 7–8.5
R: shoulder, elbow, forearm, wrist passive
training (Armeo Spring, Hocoma,
Switzerland) + usual care
C: NA
D: 24 sessions, 3 times per week for 8
weeks, 30 min/session
(+) 9HPT, TEMPA













R: shoulder, elbow, forearm, wrist
robot-assisted training (Braccio di Ferro)
with error-enhancing (EE) forces
C: shoulder, elbow, forearm, wrist
robot-assisted training (Braccio di Ferro)
with error-reducing (ER)
D: 8 sessions (4 EE, 4 ER), 2 times a week
for 4 weeks, 498 movements each session.
Session lasting 60 min.
(+) TADL in the first 4






et al., 2009 Case Series
7 PwMS: 1 PP, 4
SP, 2 RR
EDSS 4.5–6.5
R: shoulder, elbow, wrist shoulder, elbow,
forearm, wrist, robot-assisted reaching
task (Braccio di Ferro)
C: NA
D: 8 sessions, 5 times a week, 200
movements each session.








30 included studies, of which only 4 used
robotics
Robotic training is the
most studied
rehabilitation strategy in








dexterity and upper limb
functionality in PwMS.
2
1 PwMS = patients with multiple sclerosis; PP = primary progressive; SP = secondary progressive; RR = relapsing-
remitting; RP = relapsing-progressive; EDSS = expanded disability status scale; R = robotics group; C = control
group; D = dose; 9HPT = nine hole peg test; ARAT = action research arm test; FMA = fugl-meyer assessment;
MAL = motor activity log; TADL = tremor in activity of daily life; TSS = tremor severity scale; LifeH = life habits
assessment; sEMG = surface electromyography; WMFT = wolf motor function test; RT = reaching tasks; RMT
= reaching and manipulation tasks; EE = error-enhancing; RCT = randomized controlled trial; (+) = robotic
within-group significant difference.
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In the studies that reported this information [30,32,37], the most affected arm was
usually selected for robot-assisted training. In PwMS, both end-effectors [29,32,33,35–37],
a passive exoskeleton [31,34], and a hand robot [30] have been used in rehabilitation so
far. The Braccio di Ferro, a planar robotic manipulandum with 2 degrees of freedom that
can assist or contrast patients during a reaching task with either resistive, assistive, or
perturbating force fields was the most tested device in this population [29,33,35,36]. The
Amadeo® (Tyromotion-Austria), a hand robotic device with each finger attached to the
robotically driven slide, was used in a recent RCT [30]. The HapticMaster robot (MOOG,
the Netherlands), an end-effector with a 3D workspace for upper limb training, was used
in a case series and an RCT study [32,37]. Finally, the Armeo Spring (Hocoma AG, Zurich,
CH), a passive rehabilitation exoskeleton with sensors for the shoulder, elbow, and wrist
joints with gravity support for the arm in a virtual learning environment, was used in two
case series studies [31,34].
Overall, 161 PwMS (EDSS 4.5–8; 29 primary progressive, 81 secondary progressive,
49 relapsing-remitting, and 2 relapsing-progressive) were included in the clinical studies.
The RCTs included, respectively, 22 [33], 17 [32], 44 [30], and 36 [29] patients. Eight patients
were included in the crossover study [35], and the remaining 34 patients were included in
the four case series studies [31,34,36,37]. The systematic review [16] that only considered
robotic studies included 41 patients. Considering the included studies, the duration of the
robotic treatment varied from 30 to 60 min. The frequency of the therapy was about 2–5 per
week for 4–8 weeks, depending on the study, with a total number of sessions that ranged
between 8 and 40. Only one study [32] associated the robotic treatment to the conventional
one, whereas conventional therapy [30], the adjunction of object manipulation to robot-
assisted reaching tasks [33] or sensorimotor training [29] were selected as comparators.
Within-group significant differences in the robotic group were highlighted for the following
outcome measures: handgrip strength; active range of movement (ROM); Nine Hole Peg
Test (9HPT) for dexterity; Wolf Motor Function Test (WMFT) and Action Research Arm
Test (ARAT) for arm function; Tremor in Activity of Daily Life (TADL) questionnaire and
Tremor Severity Scale (TSS) for tremor; Fugl–Meyer assessment Scale (FMA) for upper limb
impairment; Life Habits assessment—general short form (LifeH), Motor Activity Log (MAL)
for upper limb use; and TEMPA for arm function during daily living activities. In addition
to clinical outcome measures, a set of robotic-driven measurements for motor control and
surface electromyography upper limb muscle activity were included in the analysis.
3.1. Effects of Upper Limb Robot-Assisted Therapy
The included systematic review [16] highlighted that robotic training is the most
studied rehabilitation intervention in upper limb rehabilitation in PwMS. In general, the
included studies (RCTs and non—RCTs) have shown that robotic training can improve
the motor coordination, manual dexterity, and functional capacity of the upper limbs.
At the body function level, maximum shoulder anteflexion (+27 degrees) and handgrip
strength (+12%) were increased in a prospective cohort study [37]. In contrast, a case series
study reported an improvement in proximal arm impairment (+15%) [31]. The tremor
was decreased after an error-enhancing adaptive robotic protocol [35]. Several studies
reported improving robot-driven measures [29,32,36,37] or EMG activity [30], but this was
only the case in the robotic group. At the activity level, manual dexterity, which was
measured by 9HPT, improved by 12–47 s in two case series studies [34,36] and only in
the robotic group (+15%) in an RCT [29]. Arm function, which was measured by WMFT,
increased by 25–33% in a prospective cohort study [37]; however, the ARAT Grasp sub-
score significantly improved in the robotic protocol that included real objects manipulation
(+77%) compared to the other condition (+29%) [33]. When measured by TEMPA tasks,
arm capacity improved (−23 s) in a case series study [34]; however, better arm use in
everyday life was only reported in the robotic group in two RCTs [30,32]. Only four
studies [29,30,34,37] had a follow-up evaluation, with retention of arm function being
shown to be maintained at one [30] or two months [34] after robotic therapy.
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3.2. Quality Assessment
The PEDro scale assessment reported that the RCTs had high quality overall [29,30,
32,33,35]. In contrast, the AMSTAR-2 assessment highlighted that the review that was
included [16] had a critically low quality. The complete quality assessment is reported in
Table 2 (PEDro) and in Table 3 (AMSTAR-2).
Table 2. Quality assessment of the RCT studies that were included using the PEDro Checklist.
Author, Year Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 PEDro Score
C. Solaro et al., 2020 Y Y N N Y N Y Y N Y Y 6
Gandolfi et al., 2018 Y Y Y Y N N Y Y N Y Y 7
Feys et al., 2015 Y Y Y Y N N N Y Y Y Y 7
Carpinella et al., 2012 Y Y N N N Y Y Y Y Y Y 7
Vergaro et al., 2010 Y Y N N Y N Y Y Y Y Y 7
Y = yes; N = no.
Table 3. Quality assessment of the systematic review that was included using the AMSTAR 2 criteria.
Author,








Abbreviations: Y = Yes, N = No, PY = partial yes, NMC = no meta-analysis conducted.
3.3. Levels of Evidence
An evidence Level of 2 was assigned to the systematic review [16] and three RCTs [29,30,32];
a level of 4 was assigned to the other studies [31,33–37].
3.4. Adverse Effects
Five of the included studies [30,31,33,34,37] considered RAT safety, reporting no
adverse effects related to the intervention.
4. Discussion
Upper limb impairment in PwMS is often under-recognized, even if it is related to
performing everyday activities that are crucial for a patient to maintain their quality of
life and participation in daily activities [11,38]. For this reason, necessary is necessary to
implement and develop effective rehabilitation strategies. This evidence-based review
aimed to systematically report the state-of-the art on clinical applications and the effec-
tiveness of robotic-assisted upper limb rehabilitation in PwMS. So far, four robotic devices
have been tested in PwMS: two end-effectors (Braccio di Ferro, HapticMaster), a passive
gravity-supported exoskeleton (Armeo Spring), and a hand-robot (Amadeo). Both the Hap-
ticMaster and Armeo Spring training movements were tested in a 3D virtual environment.
The end-effector, called Braccio di Ferro, was tested in two RCTs [29,33], one ran-
domized crossover study [35], and one case series [36]. The adaptive-type robotic therapy
for the upper limbs was feasible in PwMS and was helpful in improving manual dexter-
ity [35,36] even though no clear conclusion has been made on the best approach to improve
motor coordination in patients with cerebellar deficits [35]. Furthermore, Carpinella et al.
demonstrated in a later study that a robotic training protocol that includes reaching tasks
and object manipulation may improve movements that involve the grasping function
compared to a training protocol that only provides reaching tasks [33]. A recent paper [29]
used this device to compare robot-assisted training based on a haptic or sensorimotor
exercise in an 8-session protocol (2 per week). Patients in the haptic group had to counteract
incoordination and weakness when interacting with a virtual mass-spring system against a
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resistive load. Instead, subjects in the sensorimotor group performed reaching movements
under visual control. This study showed that haptic protocol proved to be slightly superior
(without between-group differences) to sensorimotor treatment in improving upper limb
dexterity. This could be related to amelioration in upper limb and shoulder coordination.
These improvements are most evident in prevalent pyramidal impaired subjects who were
unable to maintain the effects of rehabilitation after three months [29].
The robotic training with the Haptic Master Robot was used in an RCT [32] and in
a prospective cohort study [37]. In addition to traditional therapy, it showed significant
improvements in the quality of the movement execution in wheelchair-bound populations
and demonstrated reported beneficial effects on daily use without any adjunct impact on
clinical outcome measures [32]. By increasing the number of sessions (from 3 to 5 weeks)
and by utilizing the intervention on a less impaired population [37], significant improve-
ments were also noted in clinical parameters such as active ROM in the shoulder and the
strength and motor capacity of the upper limbs, unlike in stroke patients [37].
Two case series studies explored the effects of Armeo Spring. An 8-week long training
program (3 times per week for 30 min/session) that was implemented supplementary to
conventional therapy in high-level disability PwMS (EDSS 7.0–8.5) was able to improve
the functional capacity of the upper limbs, even after a 2-month follow-up [34]. Sampson
combined the use of the Armeo Spring with functional electric stimulation (FES). This
system assisted patients in following a specified trajectory path, employing an iterative
learning control to improve accuracy and maximize voluntary effort. An improvement of
the proximal upper limb was reported in a small group who underwent a training program
for 18 treatment sessions over 10 weeks [31]. Finally, an RCT did not find the superiority
of the hand-robot Amadeo on conventional therapy for clinical measures, even if only the
robot-assisted group reported significant improvement in arm use and an enhancement in
extensor carpi activation [30].
In conclusion, end-effector robotic devices may represent a therapeutic opportunity,
improving manual dexterity, coordination, functional capacity, and the efficiency of upper
limb motor strategies in PwMS [29,30,32,33,36,37]. However, the literature does not high-
light statistically significant benefits of RAT compared to [30] or in addition to conventional
rehabilitation [32]. Most of the included studies show that the clinical assessment does
not always confirm improvements in instrumental measurements. A possible explanation
could be related to the fact that kinematic and motor activity impairments can be present
with a normal upper limb function [39]. Moreover, robotic-driven measurements can offer a
more detailed picture of the execution of everyday daily living activities [40]. The included
studies highlight that the improvements are not always maintained until the follow-up,
except for arm function [30,34], probably because there may be no automatic transfer of the
improved task performance to the overall upper limb functionality. The use of real objects
during purposeful, functional tasks involving the whole upper limb can be a good solution
to generalize motor tasks to daily living activities. In this direction, using a planar robot
with real object manipulation has effectively ameliorated grasping function in PwMS [33].
Robot-assisted therapy has been proposed to induce neuroplastic changes and motor
recovery mainly through two different paradigms: adaptive or assistive [18]. Even though
the assistive approach is usually the most commonly applied approach in arm robotic
therapy, the evidence in PwMS is more focused on the adaptive approach with a solid
neurophysiological rationale [29,33,35,36]. This is based on the idea that PwMS preserve
their ability to adapt to a novel dynamic environment, an ability that is related to the
feed-forward component of control [9,36]. The robot did not assist subjects during the
movement execution but provided an unfamiliar dynamic environment. The subjects are
required to adapt by learning to predict the effects of perturbating forces. However, even
if motor adaptation occurred when robotic force fields were applied [35], a recent RCT
did not drive definite conclusions on the superiority of this adaptive protocol compared
to during sensorimotor training using the same device [29]. Conversely, a decrease in
tremor and cerebellar deficits was only observed when an error-enhancing paradigm was
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proposed, leading to the hypothesis that this population would be responsive to error-
based learning [35].
5. Limits and Future Directions
No meta-analysis that considered the different outcomes used, types of robotic proto-
cols, or included patients with different arm impairments concerning severity or predomi-
nant motor pattern (weakness, incoordination) was performed on the five RCTs that were
included in this evidence-based review. Moreover, due to the heterogeneity of treatment
protocols in terms of duration and frequency, it is currently not possible to demonstrate
how many weekly sessions or which therapy duration could lead to the best rehabilitative
results. In addition, all of the studies analyzed the use of end-effector robots and did
not consider the use of robotic exoskeletons, which are still not widespread in clinical
practice. The reported studies also did not report on the cost–benefit ration or the evidence
of efficiency. More RCTs with larger sample sizes and follow-up evaluations are required.
Finally, MS-specific characteristics should be addressed more deeply in future studies. As
previously reported, arm impairment is usually bilateral and usually represents different
motor deficits (weakness/incoordination, learned non-use). Future studies would be more
targeted on a specific impairment, and it is likely that a bilateral robotic arm approach
would be helpful in this population. Moreover, even if severely disabled patients are more
likely to be candidates for arm rehabilitation, functional reorganization processes could be
limited by accumulating structural CNS damage [41]. It would also be essential to imple-
ment specific protocols for PwMS in terms of duration, intensity, dose, and cognitive-motor
dysfunction according to the stage and type of the disease.
6. Conclusions
Even if arm impairment is widespread and can dramatically reduce functional abilities
and participation in PwMS, the current evidence on the use of robot-assisted therapy
in this population is still lacking and is only based on few high-quality RCTs and other
uncontrolled pilot studies. Robot-assisted treatment seems safe and useful to increase
manual dexterity and the quality of movement execution in PwMS with moderate to severe
disability. Additional studies with an adequate sample size and methodological rigour are
warranted to drive definite conclusions.
Author Contributions: G.M., M.T., E.F.R., I.A. and S.S. (Sofia Straudi) conceptualized the paper, per-
formed, and/or supervised the research. M.T., S.S. (Sofia Straudi) and E.F.R. drafted the manuscript.
L.P., M.A., M.G. (Marialuisa Gandolfi), M.P. (Matteo Paci), E.C. (Emanuela Casanova), D.M., G.L.R.,
F.B., S.S. (Silvia Sterzi), D.G., A.B., S.M. (Sandra Miccinilli), S.F., M.S. (Monica Sicari), S.P., C.M.S., S.G.
(Stefano Gargano) P.B. (Paolo Benanti), P.B. (Paolo Boldrini), D.B., E.C. (Enrico Castelli), F.D., V.F.,
S.G. (Silvia Galeri), F.G., M.G. (Mauro Grigioni), S.M. (Stefano Mazzoleni), S.M. (Stefano Mazzon),
F.M., M.P. (Maurizio Petrarca), A.P., F.P., M.S. (Michele Senatore) and G.T., members of the organizing
committee and the scientific and technical committees of the CICERONE consensus conference,
supervised the research, read and corrected the manuscript. All authors have read and agreed to the
published version of the manuscript.
Funding: The authors report no involvement in the research by the sponsor that could have influenced
the outcome of this work.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: The dataset is available on request.
Acknowledgments: The present study has been carried out within the framework of the Italian
Consensus Conference on “Rehabilitation assisted by robot and electromechanical devices for persons
with disability of neurological origin” (CICERONE), promoted by the Italian Society of Physical
and Rehabilitation Medicine (SIMFER, Società Italiana di Medicina Fisica e Riabilitativa) and Italian
Appl. Sci. 2022, 12, 222 11 of 13
Society of Neurological Rehabilitation (SIRN, Società Italiana di Riabilitazione Neurologica) (2019–
2021).
Conflicts of Interest: The authors declare no conflict of interest.
Group Name: Upper limb working group within the “Italian Consensus Conference on rehabilitation
assisted by robotic and electromechanical devices for persons with disability of neurological origin”
(CICERONE): Michela AGOSTINI (Department of Neuroscience, section of rehabilitation, University-
General Hospital of Padova, Italy); Irene APRILE (IRCCS Fondazione Don Carlo Gnocchi ONLUS
Florence, Italy); Chiara Arienti (IRCCS Fondazione Don Carlo Gnocchi ONlus, Milan, Italy), Ludovica
BALUARDO (Ferrara University Hospital, Neuroscience and Rehabilitation Department, Ferrara,
Italy); Alberto BATTISTINI (IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Medicina
Riabilitativa e Neuroriabilitazione, Bologna, Italia); Paolo BENANTI (Pontifical Gregorian University,
Rome, Italy); Valentina BOETTO (Università degli studi di Torino); Paolo BOLDRINI (Società Italiana
di Medicina Fisica e Riabilitativa, SIMFER); Donatella BONAIUTI (Istituto Società Italiana di Medic-
ina Fisica e Riabilitativa, SIMFER); Marco BRAVI (Biomedical Campus University Foundation, Rome,
Italy); Federica BRESSI (Biomedical Campus University Foundation, Rome, Italy); Diletta BRUNO
(Biomedical Campus University Foundation, Rome, Italy); Emanuela CASANOVA (IRCCS Istituto
delle Scienze Neurologiche di Bologna, UOC Medicina Riabilitativa e Neuroriabilitazione, Bologna,
Italia); Enrico CASTELLI (Paediatric Neurorehabilitation, Bambino Gesù Children’s Hospital, Rome,
Italy); Manuela DESILVESTRI (Neurorehabilitation Unit, Azienda Ospedaliera SS. Antonio e Biagio e
Cesare Arrigo, Alessandria, Italy, EU); Francesco DRAICCHIO (Department of Occupational and
Environmental Medicine, Epidemiology and Hygiene, INAIL, Monte Porzio Catone, 00185 Rome,
Italy); Vincenzo FALABELLA (President Italian Federation of Persons with Spinal Cord Injuries (Faip
Onlus), Rome, Italy); Serena FILONI (Padre Pio Foundation and Rehabilitation Centers, San Giovanni
Rotondo, Italy); Silvia GALERI (IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy); Marialuisa
GANDOLFI (Department of Neurosciences, Biomedicine and Movement Sciences, University of
Verona, Verona, Italy); Stefano GARGANO (Fondazione Don Carlo Gnocchi—Torino); Daniele GI-
ANSANTI (National Center for Innovative Technologies in Public Health, Italian National Institute
of Health, Rome, Italy); Francesca GIMIGLIANO (Department of Mental and Physical Health and
Preventive Medicine, University of Campania “Luigi Vanvitelli”, Naples, Italy); Mauro GRIGIONI
(National Center for Innovative Technologies in Public Health, Italian National Institute of Health,
Rome, Italy); Giuseppe LA ROSA (C.S.R.—Consorzio Siciliano di Riabilitazione, Catania, Italy); Dario
MARINO (IRCCS Neurolysis Center “Bonino Pulejo”, Messina, Italy); Alex MARTINO CINNERA
(Santa Lucia Foundation, IRCCS, Rome, Italy); Stefano MAZZOLENI (Department of Electrical and
Information Engineering, Politecnico di Bari, Italy); Stefano MAZZON (AULSS6 (Unique Sanitary
Local Company) Euganea Padova—Rehabilitation Department); Sandra MICCINILLI (Biomedical
Campus University Foundation, Rome, Italy); Franco MOLTENI (Villa Beretta, Costa Masnaga, Italy);
Giovanni MORONE (Santa Lucia Foundation, IRCCS, Rome, Italy); Matteo PACI (AUSL (Unique
Sanitary Local Company, District of Central Tuscany, Florence, Italy); Angela PALOMBA (Department
of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples,
Italy 31); Cristiano PECCHIOLI (Department of Neuroscience and Neurorehabilitation, IRCCS San
Raffaele Pisana, Rome, Italy); Luca PERRERO (Neurorehabilitation Unit, Azienda Ospedaliera SS. An-
tonio e Biagio e Cesare Arrigo, Alessandria, Italy); Maurizio PETRARCA (“Bambino Gesù” Children’s
Hospital—IRCCS, Movement Analysis and Robotics Laboratory MARlab, Rome, Italy); Salvatore
PETROZZINO (A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy); Alessandro PI-
CELLI (Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona,
Verona, Italy); Federico POSTERARO (Versilia Hospital AUSL Toscana Nord Ovest, Italy); Emanuele
Francesco RUSSO (Padre Pio Foundation and Rehabilitation Centers, San Giovanni Rotondo, Italy);
Fabio SANTACATERINA (Biomedical Campus University Foundation, Rome, Italy); Michele SEN-
ATORE (Past President A.I.T.O. (Associazione Italiana Terapisti Occupazionali); Monica SICARI
(A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy); Claudio Marcello SOLARO (CRRF
“Mons. Luigi Novarese” Moncrivello, VC, Italy); Silvia STERZI (Biomedical Campus University Foun-
dation, Rome, Italy); Sofia STRAUDI (Ferrara University Hospital, Neuroscience and Rehabilitation
Department, Ferrara, Italy); Giuseppe TURCHETTI (Management Institute, Sant’Anna School of
Advanced Studies, Pisa, Italy).
Appl. Sci. 2022, 12, 222 12 of 13
References
1. Compston, A.; Coles, A. Multiple sclerosis. Lancet 2008, 372, 1502–1517. [CrossRef] [PubMed]
2. Compston, A.; Coles, A. Multiple sclerosis. Lancet 2002, 359, 1221–1231. [CrossRef]
3. Johansson, S.; Ytterberg, C.; Claesson, I.M.; Lindberg, J.; Hillert, J.; Andersson, M.; Holmqvist, L.W.; von Koch, L. High concurrent
presence of disability in multiple sclerosis Associations with perceived health. J. Neurol. 2007, 254, 767–773. [CrossRef]
4. Thompson, A.J. Progress in neurorehabilitation in multiple sclerosis. Curr. Opin. Neurol. 2002, 15, 267–270. [CrossRef]
5. Koch, M.; Mostert, J.; Heersema, D.; De Keyser, J. Tremor in multiple sclerosis. J. Neurol. 2007, 254, 133–145. [CrossRef]
6. Bertoni, R.; Lamers, I.; Chen, C.C.; Feys, P.; Cattaneo, D. Unilateral and bilateral upper limb dysfunction at body functions,
activity and participation levels in people with multiple sclerosis. Mult. Scler. J. 2015, 21, 1566–1574. [CrossRef] [PubMed]
7. Lamers, I.; Cattaneo, D.; Chen, C.C.; Bertoni, R.; Van Wijmeersch, B.; Feys, P. Associations of upper limb disability measures on
different levels of the international classification of functioning, disability and health in people with multiple sclerosis. Phys. Ther.
2015, 95, 65–75. [CrossRef]
8. Pellegrino, L.; Coscia, M.; Muller, M.; Solaro, C.; Casadio, M. Evaluating upper limb impairments in multiple sclerosis by exposure
to different mechanical environments. Sci. Rep. 2018, 8, 2110. [CrossRef]
9. Casadio, M.; Sanguineti, V.; Morasso, P.; Solaro, C. Abnormal sensorimotor control, but intact force field adaptation, in multiple
sclerosis subjects with no clinical disability. Mult. Scler. J. 2008, 14, 330–342. [CrossRef] [PubMed]
10. Miller, D.M.; Allen, R. Quality of life in multiple sclerosis: Determinants, measurement, and use in clinical practice. Curr. Neurol.
Neurosci. Rep. 2010, 10, 397–406. [CrossRef]
11. Cattaneo, D.; Lamers, I.; Bertoni, R.; Feys, P.; Jonsdottir, J. Participation restriction in people with multiple sclerosis: Prevalence
and correlations with cognitive, walking, balance, and upper limb impairments. Arch. Phys. Med. Rehabil. 2017, 98, 1308–1315.
[CrossRef]
12. Kierkegaard, M.; Einarsson, U.; Gottberg, K.; Von Koch, L.; Holmqvist, L.W. The relationship between walking, manual dexterity,
cognition and activity/participation in persons with multiple sclerosis. Mult. Scler. J. 2011, 18, 639–646. [CrossRef] [PubMed]
13. Tomassini, V.; Matthews, P.M.; Thompson, A.; Fuglø, D.; Geurts, J.J.; Johansen-Berg, H.; Jones, D.K.; Rocca, M.A.; Wise, R.G.;
Barkhof, F.; et al. Neuroplasticity and functional recovery in multiple sclerosis. Nat. Rev. Neurol. 2012, 8, 635–646. [CrossRef]
14. Tomassini, V.; Johansen-Berg, H.; Leonardi, L.; Paixão, L.; Jbabdi, S.; Palace, J.; Pozzilli, C.; Matthews, P.M. Preservation of motor
skill learning in patients with multiple sclerosis. Mult. Scler. J. 2010, 17, 103–115. [CrossRef] [PubMed]
15. Feys, P.; Straudi, S. Beyond therapists: Technology-aided physical MS rehabilitation delivery. Mult. Scler. J. 2019, 25, 1387–1393.
[CrossRef] [PubMed]
16. Morone, G.; Cocchi, I.; Paolucci, S.; Iosa, M. Robot-assisted therapy for arm recovery for stroke patients: State of the art and
clinical implication. Expert Rev. Med. Devices 2020, 17, 223–233. [CrossRef]
17. Turner, D.L.; Murguialday, A.R.; Birbaumer, N.; Hoffmann, U.; Luft, A. Neurophysiology of robot-mediated training and therapy:
A perspective for future use in clinical populations. Front. Neurol. 2013, 4, 184. [CrossRef]
18. Huang, V.S.; Krakauer, W. Robotic neurorehabilitation. A computational motor learning prospective. J. Neuroeng. Rehabil. 2009, 6,
5. [CrossRef]
19. Mehrholz, J.; Pohl, M.; Platz, T.; Kugler, J.; Elsner, B. Electromechanical and robot-assisted arm training for improving activities of
daily living, arm function, and arm muscle strength after stroke. Cochrane Database Syst. Rev. 2018, 9, CD006876. [CrossRef]
20. Morone, G.; Palomba, A.; Martino Cinnera, A.; Agostini, M.; Aprile, I.; Arienti, C.; Paci, M.; Casanova, E.; Marino, D.; LARosa, G.;
et al. Systematic review of guidelines to identify recommendations for upper limb robotic rehabilitation after stroke. Eur. J. Phys.
Rehabil. Med. 2021, 57, 238–245. [CrossRef]
21. Yeh, S.-W.; Lin, L.-F.; Tam, K.-W.; Tsai, C.-P.; Hong, C.-H.; Kuan, Y.-C. Efficacy of robot-assisted gait training in multiple sclerosis:
A systematic review and meta-analysis. Mult. Scler. Relat. Disord. 2020, 41, 102034. [CrossRef] [PubMed]
22. Spooren, A.I.; Timmermans, A.A.; Seelen, H.A. Motor training programs of arm and hand in patients with MS according to
different levels of the ICF: A systematic review. BMC Neurol. 2012, 2, 12–49. [CrossRef] [PubMed]
23. Lamers, I.; Maris, A.; Severijns, D.; Dielkens, W.; Geurts, S.; Van Wijmeersch, B.; Feys, P. Upper limb rehabilitation in people with
multiple sclerosis. Neurorehabilit. Neural Repair 2016, 30, 773–793. [CrossRef] [PubMed]
24. Gimigliano, F.; Palomba, A.; Arienti, C.; Morone, G.; Perrero, L.; Agostini, M.; Aprile, I.; Paci, M.; Casanova, E.; Marino, D.; et al.
Robot-assisted arm therapy in neurological health conditions: Rationale and methodology for the evidence synthesis in the
CICERONE Italian Consensus Conference. Eur. J. Phys. Rehabil. Med. 2021, 57, 824–830. [CrossRef]
25. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and
meta-analyses: The PRISMA statement. BMJ 2009, 339, b2535. [CrossRef] [PubMed]
26. Shea, B.J.; Reeves, B.C.; Wells, G.; Thuku, M.; Hamel, C.; Moran, J.; Moher, D.; Tugwell, P.; Welch, V.; Kristjansson, E.; et al.
AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare
interventions, or both. BMJ 2017, 358, j4008. [CrossRef]
27. Moseley, A.M.; Herbert, R.; Sherrington, C.; Maher, C.G. Evidence for physiotherapy practice: A survey of the Physiotherapy
Evidence Database (PEDro). Aust. J. Physiother. 2002, 48, 43–49. [CrossRef]
28. Durieux, N.; Vandenput, S.; Pasleau, F. OCEBM levels of evidence system. Rev. Med. Liege 2013, 68, 644–649. [PubMed]
Appl. Sci. 2022, 12, 222 13 of 13
29. Solaro, C.; Cattaneo, D.; Basteris, A.; Carpinella, I.; De Luca, A.; Mueller, M.; Bertoni, R.; Ferrarin, M.; Sanguineti, V. Haptic vs
sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomized controlled
trial. J. Neurol. Sci. 2020, 412, 116743. [CrossRef]
30. Gandolfi, M.; Valè, N.; Dimitrova, E.K.; Mazzoleni, S.; Battini, E.; Benedetti, M.D.; Gajofatto, A.; Ferraro, F.; Castelli, M.; Camin,
M.; et al. Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with
multiple sclerosis: A randomized, controlled, single-blinded trial. Front. Neurol. 2018, 9, 905. [CrossRef] [PubMed]
31. Sampson, P.; Freeman, C.; Coote, S.; Demain, S.; Feys, P.; Meadmore, K.; Hughes, A.-M. Using functional electrical stimulation
mediated by iterative learning control and robotics to improve arm movement for people with multiple sclerosis. IEEE Trans.
Neural Syst. Rehabil. Eng. 2016, 24, 235–248. [CrossRef] [PubMed]
32. Feys, P.; Coninx, K.; Kerkhofs, L.; De Weyer, T.; Truyens, V.; Maris, A.; Lamers, I. Robot-supported upper limb training in a virtual
learning environment: A pilot randomized controlled trial in persons with MS. J. Neuroeng. Rehabil. 2015, 12, 60. [CrossRef]
[PubMed]
33. Carpinella, I.; Cattaneo, D.; Bertoni, R.; Ferrarin, M. Robot training of upper limb in mu tiple sclerosis: Comparing protocols with
or without manipulative task components. IEEE Trans. Neural Syst. Rehabil. Eng. 2012, 20, 351–360. [CrossRef]
34. Gijbels, D.; Lamers, I.; Kerkhofs, L.; Alders, G.; Knippenberg, E.; Feys, P. The Armeo Spring as training tool to improve upper
limb functionality in multiple sclerosis: A pilot study. J. Neuroeng. Rehabil. 2011, 8, 5. [CrossRef] [PubMed]
35. Vergaro, E.; Squeri, V.; Brichetto, G.; Casadio, M.; Morasso, P.; Solaro, C.; Sanguineti, V. Adaptive robot training for the treatment
of incoordination in Multiple Sclerosis. J. Neuroeng. Rehabil. 2010, 7, 37. [CrossRef] [PubMed]
36. Carpinella, I.; Cattaneo, D.; Abuarqub, S.; Ferrarin, M. Robot-based rehabilitation of the upper limbs in multiple sclerosis:
Feasibility and preliminary results. J. Rehabil. Med. 2009, 41, 966–970. [CrossRef] [PubMed]
37. Maris, A.; Coninx, K.; Seelen, H.; Truyens, V.; De Weyer, T.; Geers, R.; Lemmens, M.; Coolen, J.; Stupar, S.; Lamers, I.; et al. The
impact of robot-mediated adaptive I-TRAVLE training on impaired upper limb function in chronic stroke and multiple sclerosis.
Disabil. Rehabil. Assist. Technol. 2018, 13, 1–9. [CrossRef]
38. Marrie, R.A.; Cutter, G.R.; Tyry, T.; Cofield, S.S.; Fox, R.; Salter, A. Upper limb impairment is associated with use of assistive
devices and unemployment in multiple sclerosis. Mult. Scler. Relat. Disord. 2017, 13, 87–92. [CrossRef]
39. Solaro, C.; Brichetto, G.; Casadio, M.; Roccatagliata, L.; Ruggiu, P.; Mancardi, G.L.; Morasso, P.; Tanganelli, P.; Sanguineti, V.
Subtle upper limb impairment in asymptomatic multiple sclerosis subjects. Mult. Scler. J. 2007, 13, 428–432. [CrossRef]
40. Pellegrino, L.; Stranieri, G.; Tiragallo, E.; Tacchino, A.; Brichetto, G.; Coscia, M.; Casadio, M. Analysis of upper limb movement
in Multiple Sclerosis subjects during common daily actions. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2015, 2015, 6967–6970.
[CrossRef]
41. Schoonheim, M.M.; Geurts, J.J.; Barkhof, F. The limits of functional reorganization in multiple sclerosis. Neurology 2010, 74,
1246–1247. [CrossRef] [PubMed]
